Yanbing Li Selected Research

Fibrosis (Cirrhosis)

12/2023	Quantitative assessment of extraocular muscles in Graves' ophthalmopathy using T1 mapping.
8/2023	Observation of Bleeding and MACCE Events in Patients with Liver Cirrhosis Complicated with Acute Coronary Syndrome after Antiplatelet Therapy.
1/2021	IL-38 Exerts Anti-Inflammatory and Antifibrotic Effects in Thyroid-Associated Ophthalmopathy.
11/2020	Irbesartan ameliorates myocardial fibrosis in diabetic cardiomyopathy rats by inhibiting the TGFβ1/Smad2/3 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanbing Li Research Topics

Disease

38	Neoplasms (Cancer) 04/2024 - 11/2011
31	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2003
24	Influenza in Birds (Avian Flu) 11/2023 - 09/2005
15	Insulin Resistance 12/2023 - 11/2009
14	Infections 04/2024 - 01/2007
14	Papillary Thyroid Cancer 01/2024 - 06/2012
12	Thyroid Neoplasms (Thyroid Cancer) 12/2023 - 11/2011
9	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 11/2016
8	Inflammation (Inflammations) 06/2023 - 08/2005
7	Carcinogenesis 12/2023 - 08/2013
7	Thyroid Nodule (Nodule, Thyroid) 10/2023 - 06/2012
7	Obesity 04/2023 - 07/2018
7	Hyperglycemia 01/2022 - 11/2004
6	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2017
6	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2023 - 04/2016
6	Body Weight (Weight, Body) 10/2023 - 05/2015
6	Glucose Intolerance 04/2023 - 01/2016
6	Myocardial Infarction 01/2023 - 11/2016
5	Graves Ophthalmopathy 12/2023 - 09/2019
5	Hypertension (High Blood Pressure) 01/2022 - 12/2017
4	Fibrosis (Cirrhosis) 12/2023 - 11/2020
4	Hypoglycemia (Reactive Hypoglycemia) 12/2023 - 07/2018
4	Diabetes Mellitus 03/2022 - 07/2016
3	Acquired Immunodeficiency Syndrome (AIDS) 04/2024 - 01/2020
3	Hyperaldosteronism (Conn Syndrome) 03/2024 - 12/2017
3	Cognitive Dysfunction 12/2023 - 01/2023
3	Alzheimer Disease (Alzheimer's Disease) 02/2023 - 01/2021
3	Non-alcoholic Fatty Liver Disease 01/2022 - 07/2018
3	Dyslipidemias (Dyslipidemia) 01/2022 - 10/2020
3	COVID-19 11/2021 - 01/2020
3	Human Influenza (Influenza) 01/2021 - 07/2008
3	Adenoma (Adenomas) 01/2021 - 12/2017
3	Diabetic Nephropathies (Diabetic Nephropathy) 09/2016 - 01/2012
2	Wounds and Injuries (Trauma) 05/2024 - 04/2024
2	Ulcer 05/2024 - 01/2021
2	Stroke (Strokes) 04/2024 - 01/2021
2	Enteritis 11/2023 - 01/2019
2	Hemorrhage 08/2023 - 09/2021
2	Weight Loss (Weight Reduction) 03/2023 - 01/2023
2	Hypoxia (Hypoxemia) 01/2023 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 06/2019
2	Paraganglioma (Paragangliomas) 01/2022 - 10/2017
2	Pheochromocytoma 01/2022 - 10/2017
2	Diabetes Complications 01/2022 - 01/2018
2	Chronic Renal Insufficiency 01/2022 - 01/2013
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 08/2013

Drug/Important Bio-Agent (IBA)

26	Insulin (Novolin)FDA Link 01/2024 - 11/2004
26	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 03/2012
14	MicroRNAs (MicroRNA)IBA 12/2023 - 06/2012
11	VaccinesIBA 11/2023 - 10/2005
11	Biomarkers (Surrogate Marker)IBA 11/2023 - 11/2011
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2008
9	Blood Glucose (Blood Sugar)IBA 12/2023 - 01/2003
9	LipidsIBA 08/2023 - 01/2016
6	Hemagglutinins (Hemagglutinin)IBA 11/2023 - 01/2007
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2024 - 01/2021
5	CateninsIBA 02/2024 - 11/2011
5	Inactivated VaccinesIBA 11/2023 - 10/2005
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2023 - 04/2016
5	CytokinesIBA 10/2023 - 07/2016
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 11/2016
4	Peptides (Polypeptides)IBA 05/2024 - 08/2005
4	AldosteroneIBA 03/2024 - 12/2017
4	RNA (Ribonucleic Acid)IBA 12/2023 - 03/2015
4	Messenger RNA (mRNA)IBA 12/2023 - 01/2021
4	SodiumIBA 03/2023 - 01/2021
4	Long Noncoding RNAIBA 01/2023 - 07/2016
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
4	Uric Acid (Urate)IBA 01/2022 - 01/2021
4	oxidized low density lipoproteinIBA 08/2021 - 01/2014
4	Triglycerides (Triacylglycerol)IBA 08/2021 - 01/2003
4	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 08/2013
3	Circular RNAIBA 12/2023 - 01/2021
3	CreatinineIBA 05/2023 - 11/2012
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2023 - 11/2016
3	PotassiumIBA 01/2023 - 12/2017
3	omega-Chloroacetophenone (Mace)IBA 11/2021 - 11/2016
3	Hypoglycemic Agents (Hypoglycemics)IBA 11/2021 - 07/2018
3	LDL CholesterolIBA 08/2021 - 10/2020
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2020 - 09/2016
3	Amino Acids FDA Link 01/2019 - 09/2005
3	EnzymesIBA 10/2017 - 02/2015
2	Small Interfering RNA (siRNA)IBA 04/2024 - 01/2023
2	Antimicrobial PeptidesIBA 04/2024 - 01/2019
2	FilaminsIBA 04/2024 - 12/2023
2	Phosphotransferases (Kinase)IBA 02/2024 - 11/2011
2	Carrier Proteins (Binding Protein)IBA 12/2023 - 01/2015
2	Attenuated VaccinesIBA 11/2023 - 01/2007
2	Air Pollutants (Pollutants, Air)IBA 06/2023 - 01/2023
2	Cell-Free Nucleic AcidsIBA 04/2023 - 10/2020
2	ProcalcitoninIBA 01/2023 - 01/2022
2	C-Reactive ProteinIBA 01/2023 - 01/2022
2	MetanephrineIBA 01/2022 - 10/2017
2	Aldehyde Reductase (Aldose Reductase)IBA 01/2022 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2021

Therapy/Procedure

32	Therapeutics 12/2024 - 01/2003
10	Glycemic Control 10/2023 - 11/2004
3	Photochemotherapy (Photodynamic Therapy) 04/2024 - 09/2016
3	Bariatric Surgery 12/2022 - 01/2020
2	Length of Stay 11/2023 - 11/2021